OHSU is part of a clinical trial evaluating Daxor’s blood volume analyzer technology as a potential treatment for hospitalized COVID-19 patients.

Ophthalmology Times names the OHSU Casey Eye Institute is named the United States’ No. 9 ophthalmology program.

OHSU is postponing its 2020 Doernbecher Freestyle program and event, where young patients design tennis shoes that are sold to benefit Doernbecher Children’s Hospital, due to the pandemic.

In a story that notes OHSU has Oregon’s fourth-highest daily count of COVID patients, Renee Edwards, M.D., M.B.A., says the state’s hospitals are prepared for a potential future patient surge, but notes “so far, we have not reached a critical point.”

Noting Oregon’s immunization rate is low, Mary Pat Califano, B.S.N., M.B.A., R.N., describes the OHSU School of Dentistry’s program to train Oregon dentists in giving vaccines, which is now legal after to a new state law passed in 2019.

Paula Amato, M.D., and Shoukhrat Mialipov, Ph.D., respond to a Cell paper from Columbia University offering a different explanation for the results shown in their 2017 study demonstrating repair of a genetic mutation in early human embryos.

In a story regarding the stress of the 2020 election and pandemic, Avital O’Glasser, M.D., says “I'm on the frontlines at work, and balancing professional obligations with keeping my family safe has been daunting.”

Brendan O’Connell, Ph.D., presented his research, which strongly suggests the primary source of new infections in Oregon are from domestic travel, at theAmerican Society of Human Genetics 2020 Virtual Meeting.

OHSU has signed a human material and data transfer agreement with Oxford BioDynamics as part of the company’s COVID-19 disease severity test program.

The November issue of the Joint Commission Journal of Quality and Patient Safety includes an OHSU paper about using social media champions to reduce health care worker injuries.